Testing effectiveness (Phase 2)Study completedNCT02160626
What this trial is testing
Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis
Who this might be right for
Seborrheic Keratosis
Aclaris Therapeutics, Inc. 172
Showing 20 of 28 results